EFG Asset Management (Americas)’s Edwards Lifesciences EW Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3,693	Closed	-$305K	–	133
2022 Q3	$305K	Sell	3,693 -4	-0.1%	-$385	0.08%	115
2022 Q2	$352K	Sell	3,697 -709	-16%	-$73.4K	0.08%	112
2022 Q1	$519K	Sell	4,406 -515	-10%	-$57.8K	0.1%	110
2021 Q4	$638K	Sell	4,921 -281	-5%	-$32.8K	0.11%	108
2021 Q3	$589K	Buy	5,202 +208	+4%	+$23.7K	0.1%	109
2021 Q2	$517K	Buy	4,994 +778	+18%	+$73.3K	0.1%	114
2021 Q1	$353K	Buy	4,216 +922	+28%	+$77.9K	0.07%	121
2020 Q4	$301K	Sell	3,294 -156	-5%	-$12.9K	0.06%	120
2020 Q3	$275K	Buy	3,450 +254	+8%	+$19.8K	0.06%	123
2020 Q2	$221K	Buy	+3,196	New	+$227K	0.06%	120
2017 Q4	–	Sell	-8,340	Closed	-$304K	–	134
2017 Q3	$304K	Sell	8,340 -228	-3%	-$8.7K	0.12%	123
2017 Q2	$338K	Buy	+8,568	New	+$313K	0.13%	104